1 mg semaglutide Ozempic 1mg Injection – Once-Weekly GLP-1 for T2D & Cardiovascular Protection including heart disease Semaglutide (wegovy) for Weight Loss
Description
Large-scale real-world data and clinical trials indicate that GLP-1RAs reduce alcohol intake even among those without the explicit goal of quitting alcohol consumption (3)
SIBO, which means that due to an imbalance of good and bad bacteria in the small intestine the body cant digest and absorb nutrients properly
Unexpected benefits for kidney and liver disease turned up in the diabetes trials, too
GI side effects were common but manageable with dose titration
Not everyone, however, was convinced that glucagon needed to be blocked to encourage weight loss
